Related references
Note: Only part of the references are listed.miR-145 promotes miR-133b expression through c-myc and DNMT3A-mediated methylation in ovarian cancer cells
Jie Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
MiR-145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF-κB pathway regulation
Gengyu Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Mode of action of carboplatin via activating p53/miR-145 axis in head and neck cancers
Ahsen Kilic et al.
LARYNGOSCOPE (2020)
Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN
Shifang Sun et al.
LIFE SCIENCES (2020)
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis
Dan A. Erkes et al.
CANCER DISCOVERY (2020)
Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-kappa B/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer
Jin-Feng Teng et al.
CANCERS (2020)
Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis
Yan Zhang et al.
CANCER LETTERS (2020)
miR-145 improves metabolic inflammatory disease through multiple pathways
Min He et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2020)
MiR-145 negatively regulates TGFBR2 signaling responsible for sepsis-induced acute lung injury
Xiaohua Cao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway
Lianqiao Qiao et al.
FASEB JOURNAL (2019)
GSDMD is required for effector CD8+ T cell responses to lung cancer cells
Guangmin Xi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway
Lifang Ma et al.
AGING-US (2019)
Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis
J. J. Yan et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Regulation of host cell pyroptosis and cytokines production by Mycobacterium tuberculosis effector PPE60 requires LUBAC mediated NF-κB signaling
Zhen Cong et al.
CELLULAR IMMUNOLOGY (2019)
DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A
Yang Hu et al.
CLINICAL EPIGENETICS (2019)
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
Bing Xu et al.
JOURNAL OF HEPATOLOGY (2018)
DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia
Darren C. Johnson et al.
NATURE MEDICINE (2018)
Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense
Daeho So et al.
ONCOGENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
Si Ming Man et al.
IMMUNOLOGICAL REVIEWS (2017)
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Yupeng Wang et al.
NATURE (2017)
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
Stergios Boussios et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer
Radha Munagala et al.
CANCER LETTERS (2015)
Tanshinone II A Inhibits Tat-Induced HIV-1 Transactivation Through Redox-Regulated AMPK/Nampt Pathway
Hong-Sheng Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Tanshinone derivatives: a patent review (January 2006-September 2012)
Xiao-Hong Tian et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet
Suowen Xu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
Edward A. Miao et al.
NATURE IMMUNOLOGY (2010)
The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS
Guan-Wei Fan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Pyroptosis: host cell death and inflammation
Tessa Bergsbaken et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
Claire Vale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells
Tso-Hsiao Chen et al.
MITOCHONDRION (2007)
New developments in the chemistry and biology of the bioactive constituents of Tanshen
Xihong Wang et al.
MEDICINAL RESEARCH REVIEWS (2007)
Tanshinone IIA inhibits LPS-induced NF-κB activation in RAW 264.7 cells:: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways
Seon Jang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
LM Zhou et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: A gynecologic oncology group study
R Lanciano et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
